.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Mallinckrodt
Citi
Medtronic
Farmers Insurance
Deloitte
Argus Health
Cipla
Moodys

Generated: December 15, 2017

DrugPatentWatch Database Preview

ISOPTIN Drug Profile

« Back to Dashboard

When do Isoptin patents expire, and what generic alternatives are available?

Isoptin is a drug marketed by Mt Adams and is included in two NDAs.

The generic ingredient in ISOPTIN is verapamil hydrochloride. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
Drug patent expirations by year for ISOPTIN

Medical Subject Heading (MeSH) Categories for ISOPTIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mt AdamsISOPTINverapamil hydrochlorideINJECTABLE;INJECTION018485-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mt AdamsISOPTINverapamil hydrochlorideTABLET;ORAL018593-002Mar 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mt AdamsISOPTINverapamil hydrochlorideTABLET;ORAL018593-003Nov 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mt AdamsISOPTINverapamil hydrochlorideTABLET;ORAL018593-001Mar 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
Mallinckrodt
Fuji
QuintilesIMS
Queensland Health
Citi
Merck
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot